Comments on the Expansion of Induction of Buprenorphine via Telemedicine Encounter (Docket No.
DEA-948)
Categories:
Policy and Advocacy, Policy Issues, Substance Use & Opioids
Comments on the Expansion of Induction of Buprenorphine via Telemedicine Encounter (Docket No.
DEA-948)